NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

biosectinvestor,

The SAB is going to help NWBO make the choices regarding trial design and endpoints for the Phase 2 Direct trials. They will also be helping to choose the most important checkpoint blockade combination(s) for use with their DCs and the points at which any additioal optimization improvements beyond those already mentioned by them might best be encorporated. Any Phase 2 L combo trials would also look to be registrational but would more likely need to be broad enough to allow for some tweaking for safety and efficacy optimization purposes.

After all is said and done with regard to preparation for Phase 2 Direct and the SAB is still all on board, what do you think might happen to the stock price if it was announced that one of the trial endpoints was stable disease at 8 weeks? Best wishes.